sequencing-based diagnostics
Illumina, Tempus AI Collaborate on Generating Evidence for Clinical NGS-Based Testing
The companies plan to combine Tempus' multimodal data platform and Illumina's AI-driven molecular analysis technologies.
Ginkgo Bioworks, TGen, Partners Land €24M European Grant to Develop NGS-Based POC Respiratory Test
The consortium is built around a technology collaboration between Jumpcode and TGen that uses CRISPR-based targeted metagenomic sequencing to detect pathogens.
Adaptive Bio 'Confident' of MRD Reaching Profitability in 2025 as Q4 Revenues Rise 4 Percent
Premium
The Seattle-based firm booked $47.5 million in revenues during the fourth quarter while full-year revenues grew 5 percent to $179.0 million.
Adaptive Biotechnologies Q2 Revenues Drop 12 Percent as MRD Revenues Soar
The Seattle-based company saw 36 percent growth in its minimal residual disease business while making significant progress in curbing operating expenses.
Labcorp, Ultima Genomics Collaborate on NGS-Based Cancer Testing
Labcorp will use Ultima's UG100 sequencer and ppmSeq technology for minimal residual disease testing in patients with early-stage solid tumors.